ANEB (STOCKS)
ANEBULO PHARMAC INC
$0.320000
+0.020000 (+6.67%)
Prev close: $0.300000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard Anthony Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.05M
- Employees
- 3
- P/E (TTM)
- -1.65
- P/B (TTM)
- 1.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.05 | $-0.13 | +0.0826 | +62.29% |
|
Sep 2025 (Q1)
|
$-0.05 | $-0.12 | +0.0724 | +59.15% |
|
Jun 2025 (Q4)
|
$-0.05 | $-0.08 | +0.0316 | +38.73% |
|
Mar 2025 (Q3)
|
$-0.05 | $-0.12 | +0.0724 | +59.15% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.12M |
| Operating Expenses | $9.10M |
| Research and Development | $3.74M |
| Other Operating Expenses | $5.36M |
| Operating Income/Loss | -$9.10M |
| Income/Loss From Continuing Operations After Tax | -$7.98M |
| Income/Loss From Continuing Operations Before Tax | -$7.98M |
| Interest Expense, Operating | $434.00K |
| Net Income/Loss | -$7.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.19 |
| Diluted Earnings Per Share | -$0.19 |
| Basic Average Shares | 125,666,830 |
| Diluted Average Shares | 125,666,830 |
| Assets | $9.42M |
| Current Assets | $9.27M |
| Prepaid Expenses | $175.41K |
| Other Current Assets | $9.10M |
| Noncurrent Assets | $148.23K |
| Liabilities | $1.49M |
| Current Liabilities | $1.49M |
| Accounts Payable | $554.86K |
| Other Current Liabilities | $930.78K |
| Noncurrent Liabilities | $0.00 |
| Equity | $7.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.94M |
| Liabilities And Equity | $9.42M |
| Net Cash Flow From Operating Activities | -$5.84M |
| Net Cash Flow From Operating Activities, Continuing | -$5.84M |
| Net Cash Flow | $509.45K |
| Net Cash Flow, Continuing | $509.45K |
| Comprehensive Income/Loss | -$7.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.98M |
| Other Comprehensive Income/Loss | $0.00 |